Abstract:Synthetic biology is propelling medicine into a new era through its capacity to genetically program living cells. One of the particular interests is engineering bacteria as a live and targeted therapeutic delivery system. Herein, the bacterial biohybrid (E. coli-pE@PCN) is developed by genetically engineering Escherichia coli BL21 to overexpress catalase (E. coli-pE) and electrostatically adsorbing nano-sonosensitizers (PCN NPs) for enhanced and targeted sonodynamic therapy (SDT). Leveraging the ability to colonize and penetrate deep in tumors, engineered bacteria can not only sustainably express catalase to relieve tumor hypoxia, but also facilitate the enriched and expanded distribution of the carried sonosensitizer at the tumor site, so as to trigger effective SDT. More interestingly, it is found that E. coli-pE@PCN-based SDT can successfully inhibit the growth of subcutaneous and orthotopic colorectal tumors by inducing potent antitumor immune responses due to the released tumor-associated antigens and native immunogenicity of bacterial pathogen-associated molecular patterns. Furthermore, E. coli-pE@PCN-based SDT can not only prime a strong immune memory response to prevent tumor recurrence but also elicit a potent abscopal effect to inhibit tumor metastasis. Therefore, the programmable bacteria-based biohybrids developed here pave an avenue to prepare next-generation sonodynamic-immunotherapeutics to eliminate cancer and prevent its relapse and metastasis. A pioneering living biotherapeutic is developed by electrostatically attaching nano-sonosensitizers to engineered bacteria, paving the way for a synergistic sonodynamic-immunotherapy. This innovative method harnesses the power of sonodynamic therapy to facilitate the release of tumor-associated antigens and bacterial pathogen-associated molecular patterns, thereby eliciting robust anti-tumor immune responses to combat cancer progression, metastasis, and recurrence. image

Sonogenetics-controlled Synthetic Designer Cells for Cancer Therapy in Tumor Mouse Models

Ultrasound-controllable engineered bacteria for cancer immunotherapy

Programmable Bacteria‐Based Biohybrids As Living Biotherapeutics for Enhanced Cancer Sonodynamic‐Immunotherapy

Self-adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery

Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field

Probiotic Engineering and Targeted Sonoimmuno-Therapy Augmented by STING Agonist.

Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor Immunity

Programming the lifestyles of engineered bacteria for cancer therapy

Engineering of Bacteria for the Visualization of Targeted Delivery of A Cytolytic Anticancer Agent

Engineered Bacteria: Strategies and Applications in Cancer Immunotherapy

Engineered Oncolytic Bacteria for Malignant Solid Tumor Treatment

Synthetic bacteria with programmed cell targeting and protein injection suppress tumor growth

Upconversion Optogenetic Engineered Bacteria System for Time-Resolved Imaging Diagnosis and Light-Controlled Cancer Therapy

Engineered NIR light-responsive bacteria as anti-tumor agent for targeted and precise cancer therapy

Tweak to Treat: Reprograming Bacteria for Cancer Treatment

Bacteria engineered with intracellular and extracellular nanomaterials for hierarchical modulation of antitumor immune responses

In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity

Development of a Bacteria-Nanosapper for the Active Delivery of ZIF-8 Particles Containing Therapeutic Genes for Cancer Immune Therapy

A programmable encapsulation system improves delivery of therapeutic bacteria in mice

Near‐Infrared Nano‐Optogenetic Activation of Cancer Immunotherapy via Engineered Bacteria

Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity